Growth Metrics

Lemaitre Vascular (LMAT) Gross Profit (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Gross Profit for 16 consecutive years, with $46.2 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 19.69% to $46.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $178.5 million through Dec 2025, up 18.32% year-over-year, with the annual reading at $178.5 million for FY2025, 18.32% up from the prior year.
  • Gross Profit for Q4 2025 was $46.2 million at Lemaitre Vascular, up from $46.0 million in the prior quarter.
  • The five-year high for Gross Profit was $46.2 million in Q4 2025, with the low at $23.8 million in Q1 2021.
  • Average Gross Profit over 5 years is $33.1 million, with a median of $31.5 million recorded in 2023.
  • The sharpest move saw Gross Profit skyrocketed 57.15% in 2021, then rose 0.38% in 2022.
  • Over 5 years, Gross Profit stood at $26.0 million in 2021, then rose by 0.38% to $26.1 million in 2022, then grew by 27.68% to $33.3 million in 2023, then rose by 16.01% to $38.6 million in 2024, then increased by 19.69% to $46.2 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $46.2 million, $46.0 million, and $45.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.